FDA Panel To Give New Sanofi Cholestrol Drug A Closer Look
U.S. Food and Drug Administration staff said Friday that clinical trials have shown that Sanofi SA's new cholesterol drug "significantly lowered" harmful cholesterol compared with patients who were taking existing statin...To view the full article, register now.
Already a subscriber? Click here to view full article